- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04529447
Response of Korean Medicine Hospital to COVID-19
July 20, 2022 updated by: Jaseng Hospital of Korean Medicine
Hospital Operational Response Strategy and Experience During the COVID-19 Pandemic in a Spine-specialty Korean Medicine Training Hospital
The objectives of this study are to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital, and the satisfaction survey results regarding its preventive measures.
Study Overview
Detailed Description
The objectives of this study are (1) to report the response strategy to prevent COVID-19 spread implemented at a Korean medicine hospital situated in Seoul, Korea, (2) to describe patient visit trends compared to the number of confirmed COVID-19 cases during the COVID-19 peak in February - April 2020, and (3) to provide results of a satisfaction survey regarding its preventive measures.
Study Type
Observational
Enrollment (Actual)
485
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Seoul, Korea, Republic of, 06110
- Jaseng Hospital of Korean Medicine
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Yes
Genders Eligible for Study
All
Sampling Method
Non-Probability Sample
Study Population
Inpatients hospitalized and outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020
Description
Inclusion Criteria:
- Inpatients hospitalized at Jaseng Hospital of Korean medicine during March 23-25, 2020
- Outpatients visiting Jaseng Hospital of Korean medicine during March 23-25, 2020
Exclusion Criteria:
- Visitors visiting Jaseng Hospital of Korean medicine during March 23-25, 2020 for purposes other than treatment
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Patient satisfaction survey
Jaseng Hospital of Korean medicine conducted a pen and paper survey on patient satisfaction with regard to its COVID-19 response in inpatients hospitalized and outpatients visiting during March 23-25, 2020.
|
The patient satisfaction survey consisted of 8 items, including 7 Likert scale questions and 1 multiple choice question.
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Satisfactory service regarding hospital response to COVID-19
Time Frame: Baseline (time of current visit)
|
Multiple choice question on satisfactory service regarding hospital response to COVID-19, if any
|
Baseline (time of current visit)
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Feelings of apprehension regarding hospital visits
Time Frame: Baseline (time of current visit)
|
Likert scale question on level of feelings of apprehension before hospital visits due to COVID-19
|
Baseline (time of current visit)
|
|
Medical staff wearing of facial masks and hand hygiene
Time Frame: Baseline (time of current visit)
|
Likert scale question on level of maintenance of wearing of facial masks and hand hygiene in medical staff
|
Baseline (time of current visit)
|
|
Cleanliness and sterilization of hospital facilities
Time Frame: Baseline (time of current visit)
|
Likert scale question on level of cleanliness and sterilization of hospital facilities with regard to COVID-19 spread prevention
|
Baseline (time of current visit)
|
|
Convenience and accessibility of hand sanitizers
Time Frame: Baseline (time of current visit)
|
Likert scale question on level of convenience and accessibility of hand sanitizers
|
Baseline (time of current visit)
|
|
Helpfulness and readability of posters and stand-up banners
Time Frame: Baseline (time of current visit)
|
Likert scale question on level of helpfulness and readability of posters and stand-up banners with COVID-19 information in the hospital
|
Baseline (time of current visit)
|
|
Satisfaction with hospital safety measures for COVID-19
Time Frame: Baseline (time of current visit)
|
Likert scale question on level of satisfaction with hospital safety measures for COVID-19
|
Baseline (time of current visit)
|
|
Recommendation of hospital to friends and family
Time Frame: Baseline (time of current visit)
|
Likert scale question on level of recommendation of this hospital to friends and family concerned with visiting hospitals due to COVID-19
|
Baseline (time of current visit)
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Jinho Lee, KMD, Ph.D., Jaseng Hospital of Korean Medicine
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
June 10, 2020
Primary Completion (Actual)
August 10, 2020
Study Completion (Actual)
August 10, 2020
Study Registration Dates
First Submitted
August 26, 2020
First Submitted That Met QC Criteria
August 26, 2020
First Posted (Actual)
August 27, 2020
Study Record Updates
Last Update Posted (Actual)
July 22, 2022
Last Update Submitted That Met QC Criteria
July 20, 2022
Last Verified
July 1, 2022
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- JMA-CT-2020-01
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Covid19
-
Anavasi DiagnosticsNot yet recruiting
-
Ain Shams UniversityRecruiting
-
Israel Institute for Biological Research (IIBR)Completed
-
Colgate PalmoliveCompleted
-
Christian von BuchwaldCompleted
-
Luye Pharma Group Ltd.Shandong Boan Biotechnology Co., LtdActive, not recruiting
-
University of ZurichLabor Speiz; Swiss Armed Forces; Universitatsspital ZurichEnrolling by invitation
-
Alexandria UniversityCompleted
Clinical Trials on Survey
-
Johns Hopkins Bloomberg School of Public HealthPontificia Universidad JaverianaCompletedNoncommunicable Diseases | Surveys and QuestionnairesColombia
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)CompletedSarcoma | Breast Carcinoma | Head and Neck CarcinomaUnited States
-
Weill Medical College of Cornell UniversityBoston Children's Hospital; Brigham and Women's Hospital; The Commonwealth FundCompletedPediatric ALLUnited States
-
Assistance Publique - Hôpitaux de ParisURC-CIC Paris Descartes Necker Cochin; Université de Cergy PontoiseCompleted
-
Sarasota Memorial Health Care SystemEnrolling by invitation
-
Ohio State UniversityWithdrawnMedicare Part DUnited States
-
Johns Hopkins Bloomberg School of Public HealthIfakara Health InstituteCompletedNoncommunicable Diseases | Surveys and QuestionnairesTanzania
-
Memorial Sloan Kettering Cancer CenterCompletedInpatients With Limited English ProficiencyUnited States
-
Lawson Health Research InstituteCompletedEvaluation of an Introductory Videotape Intervention to Improve Cardiac Rehabilitation ParticipationMyocardial Infarction | Unstable Angina | Coronary Angioplasty | Coronary Artery Bypass SurgeryCanada